<code id='B4229C8A27'></code><style id='B4229C8A27'></style>
    • <acronym id='B4229C8A27'></acronym>
      <center id='B4229C8A27'><center id='B4229C8A27'><tfoot id='B4229C8A27'></tfoot></center><abbr id='B4229C8A27'><dir id='B4229C8A27'><tfoot id='B4229C8A27'></tfoot><noframes id='B4229C8A27'>

    • <optgroup id='B4229C8A27'><strike id='B4229C8A27'><sup id='B4229C8A27'></sup></strike><code id='B4229C8A27'></code></optgroup>
        1. <b id='B4229C8A27'><label id='B4229C8A27'><select id='B4229C8A27'><dt id='B4229C8A27'><span id='B4229C8A27'></span></dt></select></label></b><u id='B4229C8A27'></u>
          <i id='B4229C8A27'><strike id='B4229C8A27'><tt id='B4229C8A27'><pre id='B4229C8A27'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:143
          A vial of Tofersen injection on the left of its box
          The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

          LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

          The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

          advertisement

          The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          American woman, child freed after being kidnapped in Haiti last month
          American woman, child freed after being kidnapped in Haiti last month

          0:26InthisundatedphotoprovidedbyElRoiHaiti,AlixDorsainvil,right,poseswithherhusband,SandroDorsainvil

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Amylyx's ALS drug launch starts strong. It could be trouble for FDA

          MollyFerguson/STATBehindthestellarcommerciallaunchofAmylyxPharmaceuticals’treatmentforALSliesanuncom